Lightning Round: Should have struck gold already

It's that time again! The Lightning Round bell has rung, and Jim Cramer gives his take on a few favorite audience stocks:

Dicerna Pharmaceuticals: "This company has been around for a while...I think it should have struck gold already by now. I'm on hold on this one."

Ziopharm Oncology: "This one is too much of a battleground. It's been up and down, and up and down. I have to say don't buy because the longs and shorts are going at it with this one."

Akamai Technologies: "This is a content delivery system, and I think it's terrific. We keep proliferating, and I think in all sorts of different ways it's a connectivity play. I like it."

Lion Biotechnologies: "I do like this one very much and I wish we hadn't missed a little bit of it, but this is one that comes in with the JUNO and the HALO and it works for me."

Read more from Mad Money with Jim Cramer
Cramer Remix: Stocks to buy ahead of Fed meeting
Cramer: Market trends? Not your friend
Cramer: Big decisions to be made now

Antero Resources Corporation: "I think these guys came to the market at the wrong time, and paid too much for things. I'm going to stay away from that one."

Five Below: "I'm nervous about Five Below, and it feels a little bit more like an REI than it does for a stock that's down....we are going to stay away from Five Below when there are so many great companies like Ross Stores around. That's where I want you to go, and I know they're not totally comparable."

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram - Vine

Questions, comments, suggestions for the "Mad Money" website?